Essentially, the study established a direct correlation between increased expression of the three enzymes and tumor aggressiveness: elevated levels of LPL, FATP2, and CPT1A were associated with lymph node metastasis and more advanced tumor stages. The gene discussed is SLC27A2; the disease is neoplasm.